loadpatents
name:-0.0042350292205811
name:-0.0022909641265869
name:-0.00033998489379883
Petersen; Kamille Dumong Patent Filings

Petersen; Kamille Dumong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Petersen; Kamille Dumong.The latest application filed is for "histone deacetylase (hdac) inhibitors for the treatment of cancer".

Company Profile
0.5.10
  • Petersen; Kamille Dumong - Copenhagen DK
  • Petersen; Kamille Dumong - Lyngby DK
  • Petersen; Kamille Dumong - Lejre DK
  • Petersen; Kamille Dumong - Legre DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Cancer
App 20140348823 - Lichenstein; Henri ;   et al.
2014-11-27
Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent
Grant 8,828,392 - Lichenstein , et al. September 9, 2
2014-09-09
Oligomeric Compounds For The Modulation Of Survivin Expression
App 20120088907 - Hansen; Bo ;   et al.
2012-04-12
Oligomeric compounds for the modulation of survivin expression
Grant 8,026,355 - Hansen , et al. September 27, 2
2011-09-27
Oligomeric Compounds For The Modulation Of Survivin Expression
App 20100292311 - Hansen; Bo ;   et al.
2010-11-18
Oligomeric compounds for the modulation of survivin expression
Grant 7,741,309 - Hansen , et al. June 22, 2
2010-06-22
Oligomeric compounds for the modulation of survivin expression
Grant 7,713,738 - Hansen , et al. May 11, 2
2010-05-11
Oligomeric Compounds For The Modulation Of Survivin Expression
App 20090318362 - Hansen; Jens Bo rode ;   et al.
2009-12-24
Histone Deacetylase (Hdac) Inhibitors (Pxd101) for the Treatment of Cancer Alone or in Combination With Chemotherapeutic Agent
App 20080274120 - Lichenstein; Henri ;   et al.
2008-11-06
Combination Therapies Using Hdac Inhibitors
App 20080213399 - Lichenstein; Henri ;   et al.
2008-09-04
Oligomeric compounds for the modulation ras expression
App 20080188432 - Hansen; Bo ;   et al.
2008-08-07
Oligomeric compounds for the modulation survivin expression
App 20050014712 - Hansen, Bo ;   et al.
2005-01-20
Oligomeric compounds for the modulation of ras expression
App 20040248840 - Hansen, Bo ;   et al.
2004-12-09
Oligomeric compounds for the modulation of thioredoxin expression
App 20040241717 - Hansen, Bo ;   et al.
2004-12-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed